• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突变型 p53 癌细胞在细胞自噬性吞噬作用下的基因组不稳定性。

Genomic instability in mutant p53 cancer cells upon entotic engulfment.

机构信息

MRC Toxicology Unit, Lancaster Road, Leicester, LE1 9HN, UK.

Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK.

出版信息

Nat Commun. 2018 Aug 3;9(1):3070. doi: 10.1038/s41467-018-05368-1.

DOI:10.1038/s41467-018-05368-1
PMID:30076358
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6076230/
Abstract

Cell-in-cell (CIC) structures are commonly seen in tumours. Their biological significance remains unclear, although they have been associated with more aggressive tumours. Here we report that mutant p53 promotes CIC via live cell engulfment. Engulfed cells physically interfere in cell divisions of host cells and for cells without p53 this leads to host cell death. In contrast, mutant p53 host cells survive, display aberrant divisions, multinucleation and tripolar mitoses. In xenograft studies, CIC-rich p53 mutant/null co-cultures show enhanced tumour growth. Furthermore, our results show that CIC is common within lung adenocarcinomas, is an independent predictor of poor outcome and disease recurrence, is associated with mutant p53 expression and correlated to measures of heterogeneity and genomic instability. These findings suggest that pro-tumorigenic entotic engulfment activity is associated with mutant p53 expression, and the two combined are a key factor in genomic instability.

摘要

细胞中包含细胞(CIC)结构在肿瘤中很常见。尽管它们与更具侵袭性的肿瘤有关,但它们的生物学意义尚不清楚。在这里,我们报告突变型 p53 通过活细胞吞噬作用促进 CIC。被吞噬的细胞会在物理上干扰宿主细胞的细胞分裂,而对于没有 p53 的细胞,这会导致宿主细胞死亡。相比之下,突变型 p53 宿主细胞存活下来,表现出异常分裂、多核化和三极有丝分裂。在异种移植研究中,富含 CIC 的 p53 突变体/缺失共培养显示出增强的肿瘤生长。此外,我们的结果表明,CIC 在肺腺癌中很常见,是预后不良和疾病复发的独立预测因子,与突变型 p53 表达相关,并与异质性和基因组不稳定性的衡量标准相关。这些发现表明,促肿瘤发生的胞噬性吞噬作用与突变型 p53 表达有关,两者的结合是基因组不稳定性的关键因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b2/6076230/8cb5e763b0a0/41467_2018_5368_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b2/6076230/b3c66651c6a2/41467_2018_5368_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b2/6076230/f554e16d1c74/41467_2018_5368_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b2/6076230/b7fae59bc6c1/41467_2018_5368_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b2/6076230/79de900dc4e3/41467_2018_5368_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b2/6076230/bf0ac1fbf0d0/41467_2018_5368_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b2/6076230/a019d31fda26/41467_2018_5368_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b2/6076230/8cb5e763b0a0/41467_2018_5368_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b2/6076230/b3c66651c6a2/41467_2018_5368_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b2/6076230/f554e16d1c74/41467_2018_5368_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b2/6076230/b7fae59bc6c1/41467_2018_5368_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b2/6076230/79de900dc4e3/41467_2018_5368_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b2/6076230/bf0ac1fbf0d0/41467_2018_5368_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b2/6076230/a019d31fda26/41467_2018_5368_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50b2/6076230/8cb5e763b0a0/41467_2018_5368_Fig7_HTML.jpg

相似文献

1
Genomic instability in mutant p53 cancer cells upon entotic engulfment.突变型 p53 癌细胞在细胞自噬性吞噬作用下的基因组不稳定性。
Nat Commun. 2018 Aug 3;9(1):3070. doi: 10.1038/s41467-018-05368-1.
2
NKX2-1-mediated p53 expression modulates lung adenocarcinoma progression via modulating IKKβ/NF-κB activation.NKX2-1介导的p53表达通过调节IKKβ/NF-κB激活来调控肺腺癌进展。
Oncotarget. 2015 Jun 10;6(16):14274-89. doi: 10.18632/oncotarget.3695.
3
SLC25A1, or CIC, is a novel transcriptional target of mutant p53 and a negative tumor prognostic marker.溶质载体家族25成员1(SLC25A1),即癌症相关基因(CIC),是突变型p53的一种新型转录靶点和负性肿瘤预后标志物。
Oncotarget. 2014 Mar 15;5(5):1212-25. doi: 10.18632/oncotarget.1831.
4
Lung tumors with distinct p53 mutations respond similarly to p53 targeted therapy but exhibit genotype-specific statin sensitivity.具有明显 p53 突变的肺肿瘤对 p53 靶向治疗有相似的反应,但表现出基因型特异性的他汀类药物敏感性。
Genes Dev. 2017 Jul 1;31(13):1339-1353. doi: 10.1101/gad.298463.117. Epub 2017 Aug 8.
5
Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke.暴露于香烟烟雾中的p53突变小鼠的分子改变与肺肿瘤
Cancer Res. 2003 Feb 15;63(4):793-800.
6
Tp53 determines the spatial dynamics of M1/M2 tumor-associated macrophages and M1-driven tumoricidal effects.Tp53决定了M1/M2肿瘤相关巨噬细胞的空间动态以及M1驱动的杀瘤效应。
Cell Death Dis. 2025 Jan 22;16(1):38. doi: 10.1038/s41419-025-07346-0.
7
YTHDF1 Promotes Cyclin B1 Translation through mA Modulation and Contributes to the Poor Prognosis of Lung Adenocarcinoma with KRAS/TP53 Co-Mutation.YTHDF1 通过 mA 调控促进细胞周期蛋白 B1 的翻译,促进 KRAS/TP53 共突变肺腺癌的不良预后。
Cells. 2021 Jul 2;10(7):1669. doi: 10.3390/cells10071669.
8
Tumor regression and resistance mechanisms upon CDK4 and RAF1 inactivation in KRAS/P53 mutant lung adenocarcinomas.KRAS/P53 突变型肺腺癌中 CDK4 和 RAF1 失活后的肿瘤消退和耐药机制。
Proc Natl Acad Sci U S A. 2020 Sep 29;117(39):24415-24426. doi: 10.1073/pnas.2002520117. Epub 2020 Sep 10.
9
Type of TP53 mutation influences oncogenic potential and spectrum of associated K-ras mutations in lung-specific transgenic mice.TP53 基因突变类型影响肺特异性转基因小鼠中的致癌潜能和相关 K-ras 突变谱。
Int J Cancer. 2019 Nov 1;145(9):2418-2426. doi: 10.1002/ijc.32279. Epub 2019 Apr 13.
10
p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression.p53 突变体与 HIF-1 合作,对细胞外基质成分进行转录调控,促进肿瘤进展。
Proc Natl Acad Sci U S A. 2018 Nov 13;115(46):E10869-E10878. doi: 10.1073/pnas.1808314115. Epub 2018 Oct 31.

引用本文的文献

1
S1PR5 as a prognostic biomarker in colon cancer: insights into efferocytosis-related mechanisms and immune modulation.S1PR5作为结肠癌的预后生物标志物:对胞葬作用相关机制和免疫调节的见解
J Mol Histol. 2025 Sep 15;56(5):315. doi: 10.1007/s10735-025-10608-y.
2
Multiplex analysis of colorectal cancer tissue describes the composition, cell biology and spatial effects of cell-in-cell events and identifies a T cell-dependent prognostic signature.结直肠癌组织的多重分析描述了细胞内细胞事件的组成、细胞生物学和空间效应,并确定了一种T细胞依赖性预后特征。
bioRxiv. 2025 Jul 18:2025.07.15.662825. doi: 10.1101/2025.07.15.662825.
3
Mutant p53 induces SH3BGRL expression to promote cell engulfment.

本文引用的文献

1
Mitosis can drive cell cannibalism through entosis.有丝分裂可通过细胞内吞作用驱动细胞自噬。
Elife. 2017 Jul 11;6:e27134. doi: 10.7554/eLife.27134.
2
Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution.系统发育ctDNA分析描绘了早期肺癌的演变。
Nature. 2017 Apr 26;545(7655):446-451. doi: 10.1038/nature22364.
3
Tracking the Evolution of Non-Small-Cell Lung Cancer.跟踪非小细胞肺癌的演变。
突变型p53诱导SH3BGRL表达以促进细胞吞噬。
Cell Death Discov. 2025 Jul 1;11(1):288. doi: 10.1038/s41420-025-02582-x.
4
Colorectal cancer stem cells develop NK cell resistance via homotypic cell-in-cell structures suppressed by Stathmin1.结直肠癌干细胞通过被Stathmin1抑制的同型细胞内细胞结构产生对自然杀伤细胞的抗性。
Theranostics. 2025 Mar 18;15(10):4308-4324. doi: 10.7150/thno.110379. eCollection 2025.
5
p53-regulated non-apoptotic cell death pathways and their relevance in cancer and other diseases.p53调控的非凋亡性细胞死亡途径及其在癌症和其他疾病中的相关性。
Nat Rev Mol Cell Biol. 2025 Apr 9. doi: 10.1038/s41580-025-00842-3.
6
ROCK signaling is involved in the entosis of both nonepithelial and epithelial tumors, whereas N‑cadherin is involved in the entosis of nonepithelial tumors.ROCK信号传导参与非上皮性肿瘤和上皮性肿瘤的细胞自噬,而N-钙黏蛋白参与非上皮性肿瘤的细胞自噬。
Exp Ther Med. 2025 Mar 7;29(5):90. doi: 10.3892/etm.2025.12840. eCollection 2025 May.
7
Cell hiding in colorectal cancer: correlation with response to chemotherapy in vitro and in vivo.细胞藏身于结直肠癌中:与体外和体内化疗反应的相关性。
Sci Rep. 2024 Nov 20;14(1):28762. doi: 10.1038/s41598-024-79948-1.
8
A bibliometric and visualization analysis of entosis research from 2007 to 2024.2007年至2024年细胞内吞研究的文献计量与可视化分析
Front Oncol. 2024 Oct 28;14:1424100. doi: 10.3389/fonc.2024.1424100. eCollection 2024.
9
CT45A1-mediated MLC2 (MYL9) phosphorylation promotes natural killer cell resistance and outer cell fate in a cell-in-cell structure, potentiating the progression of microsatellite instability-high colorectal cancer.CT45A1介导的肌球蛋白轻链2(MYL9)磷酸化促进细胞内细胞结构中的自然杀伤细胞抗性和外细胞命运,增强微卫星高度不稳定型结直肠癌的进展。
Mol Oncol. 2025 Feb;19(2):430-451. doi: 10.1002/1878-0261.13736. Epub 2024 Sep 25.
10
Homotypic cell-in-cell structure as a novel prognostic predictor in non-small cell lung cancer and frequently localized at the invasive front.同源细胞-细胞结构作为非小细胞肺癌的一种新的预后预测因子,常位于侵袭前沿。
Sci Rep. 2024 Aug 15;14(1):18952. doi: 10.1038/s41598-024-69833-2.
N Engl J Med. 2017 Jun 1;376(22):2109-2121. doi: 10.1056/NEJMoa1616288. Epub 2017 Apr 26.
4
Mutant p53 perturbs DNA replication checkpoint control through TopBP1 and Treslin.突变型p53通过TopBP1和Treslin扰乱DNA复制检查点控制。
Proc Natl Acad Sci U S A. 2017 May 9;114(19):E3766-E3775. doi: 10.1073/pnas.1619832114. Epub 2017 Apr 24.
5
Mutant p53 establishes targetable tumor dependency by promoting unscheduled replication.突变型p53通过促进异常复制建立可靶向的肿瘤依赖性。
J Clin Invest. 2017 May 1;127(5):1839-1855. doi: 10.1172/JCI87724. Epub 2017 Apr 10.
6
From leukocyte recruitment to resolution of inflammation: the cardinal role of integrins.从白细胞募集到炎症消退:整合素的核心作用
J Leukoc Biol. 2017 Sep;102(3):677-683. doi: 10.1189/jlb.3MR0117-024R. Epub 2017 Mar 14.
7
EGFR-mediated macrophage activation promotes colitis-associated tumorigenesis.表皮生长因子受体(EGFR)介导的巨噬细胞激活促进结肠炎相关的肿瘤发生。
Oncogene. 2017 Jul 6;36(27):3807-3819. doi: 10.1038/onc.2017.23. Epub 2017 Mar 6.
8
Novel targets and interaction partners of mutant p53 Gain-Of-Function.突变型p53功能获得的新型靶点及相互作用伙伴
Biochem Soc Trans. 2016 Apr 15;44(2):460-6. doi: 10.1042/BST20150261.
9
Mechanisms and consequences of entosis.细胞自噬的机制与后果。
Cell Mol Life Sci. 2016 Jun;73(11-12):2379-86. doi: 10.1007/s00018-016-2207-0. Epub 2016 Apr 5.
10
Mutant p53 Drives Cancer by Subverting Multiple Tumor Suppression Pathways.突变型p53通过颠覆多种肿瘤抑制途径驱动癌症。
Front Oncol. 2016 Jan 27;6:12. doi: 10.3389/fonc.2016.00012. eCollection 2016.